Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADD-IT1: Adjuncts to Immunotherapy in Advanced Cancers
NCT07836712Phase 2Not yet recruiting
- Sponsor
- University of Southern California
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol, desloratadine, magnesium sulfate, vitamin d in melanoma, hepatocellular carcinoma (HCC), sponsored by University of Southern California. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
propranololdesloratadinemagnesium sulfatevitamin d
03
Conditions
melanomahepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07836712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836712.